ROR1 and ovarian carcinoma: Different to the oncogenic role of the two receptors in ovarian cancer where both receptors are overexpressed and associated with survival [16], our previous study in EC suggested distinct roles for ROR1 and ROR2, with high ROR1 and low ROR2 expression associated with shorter survival [17].